Federal Court Rules In Favor Of Permanent Injunction In InMode Counterfeit Device Case

The U.S. District Court for the Central District of California has ruled in favor of InMode Ltd., granting a default judgment against multiple DHGate sellers accused of promoting and distributing counterfeit aesthetic medical devices, the company announced in a press release. 

In its May 6 decision, the court found the defendants liable for trademark infringement, false designation of origin, and unfair competition under California law. The ruling enjoins the sellers from further use of the MORPHEUS® and INMODE® trademarks and orders the removal of infringing listings and the freezing of associated assets. Damages were also awarded to InMode on a per-defendant basis.

According to InMode, the judgment reinforces the company’s stance on protecting both its intellectual property and public safety. “InMode maintains a zero-tolerance policy towards fraudulent business practices including counterfeit goods and for any platforms or sellers who are using, selling, or distributing false products,” said CEO Moshe Mizrahy. He emphasized the company’s ongoing efforts to prevent harm to consumers from unauthorized Morpheus8 devices.

As part of those efforts, InMode has implemented a Verified Provider Program for its Morpheus8 technology. The initiative enables certified clinics to demonstrate their legitimacy and reassures patients that they are receiving treatments using genuine InMode equipment.